2011 Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY 2011 Annual Report www.faseb.org/centennial The Federation of American Societies for Experimental Biology (FASEB) advances health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy. FASEB Member Societies APS The American Physiological Society SSR Society for the Study of Reproduction ASBMB American Society for Biochemistry and TS The Teratology Society Molecular Biology TES The Endocrine Society ASPET American Society for Pharmacology and Experimental Therapeutics ASHG The American Society of Human Genetics ASIP American Society for Investigative Pathology EMS Environmental Mutagen Society ASN American Society for Nutrition ISCB International Society for Computational Biology AAI The American Association of Immunologists ACSM American College of Sports Medicine AAA American Association of Anatomists BMES Biomedical Engineering Society PS The Protein Society GSA Genetics Society of America SDB Society for Developmental Biology AFMR American Federation for Medical Research APEPS American Peptide Society HCS The Histochemical Society ABRF Association of Biomolecular Resource Facilities SPR Society for Pediatric Research* ASBMR The American Society for Bone and SFG Society for Glycobiology* Mineral Research ASCI The American Society for Clinical *Membership approved by the Board of Directors December 5, 2011. Investigation Effective date of membership, January 1, 2012. Now representing over 100,000 researchers. Table of Contents President’s Report 2 Executive Director’s Report 3 Public Affairs 4 The FASEB Journal 8 Science Research Conferences 10 MARC: Maximizing Access to Research Careers 11 Society Management Services 12 Beaumont Campus 14 FASEB Awards 15 FASEB’s New Logo 16 Financial Report 17 FASEB Committees 22 FASEB Member Societies 25 FASEB Departments 29 Thank you to our volunteers. FASEB Board Officers Directors President Parker B. Antin AAA Virendra B. Mahesh SSR Joseph C. LaManna Thomas M. Badger ASN Maurice Manning APEPS President-Elect Judith A. Blake ISCB Elizabeth McNally ASCI Judith S. Bond Shu Chien BMES Carole Mendelson TES Past-President William T. Talman Sylvia Christakos ASBMR Francis J. Miller AFMR Vice President for Science Policy Brian Cox ASPET James M. Musser ASIP Margaret K. Offermann Garry R. Cutting ASHG Laura Niedernhofer EMS Treasurer Nancy Denslow ABRF Arthur G. Palmer PS Fred D. Finkelman R. Scott Hawley GSA Chester Ray ACSM Secretary Joseph R. Haywood APS Edward Rosa-Molinar HCS Guy Fogleman Ellen Kraig AAI Peter A. Rubenstein ASBMB Carole LaBonne SDB Anthony R. Scialli TS Advisors Other Leadership Positions Terry Gaasterland ISCB Immediate Past-Vice President for Science Policy Bettie Sue Masters ASBMB Judith S. Bond Patricia Morris SSR Vice President-Elect for Science Policy Joseph R. Haywood Abdulla Salahudeen AFMR Treasurer-Elect All information reported as of Lynn Wecker December 31, 2011 FASEB Annual Report 2011 1 Joseph C. LaManna President’s Report For FASEB, 2011 began with a desperate fight to avoid the the role of basic scientists in translational research. NIH $1.6 billion funding cut for the National Institutes of Health Director Francis Collins gave the keynote address at this (NIH) contained in H.R. 1, the first bill to come out of the new event that drew participants from all across the nation. The 112th Congress. We ended the year, however, with small senior leadership from seven of the NIH Institutes attended increases in the budgets of NIH, the National Science Foun- the meeting, which was supported by the Howard Hughes dation (NSF) and the Department of Energy (DOE). From Medical Institute, the Veterans Administration, the Merck the perspective of the bottom line, it was a year of modest Foundation, the Doris Duke Foundation, and the Burroughs success. But the effort needed to reach this outcome was Wellcome Fund. anything but incremental. As “the voice of biomedical researchers,” policy makers Early in the year, William T. Talman (Immediate Past- continued to look to FASEB for guidance. I was asked to President) met with key staff for the newly elected Speaker speak at an Institute of Medicine (IOM) meeting on conflict of of the House John Boehner and House Majority Leader interest policy (July 7) and a National Academy of Sciences Eric Cantor. His letters to members of Congress and his meeting on teaching evolution (October 25). Kevin Kregel, testimony before the House Commerce Justice Science Chair of the Animals in Research Subcommittee was invited Appropriations Subcommittee on March 11 continued the to address the IOM committee studying the use of chim- effort. A few weeks later, on March 29, FASEB held its Capitol panzees in research (May 26), and he also represented Hill Day during which scientists from across the country FASEB in meetings on this topic with congressional offices held meetings in 45 congressional offices. After becoming and Executive Branch agencies. president of FASEB in July, I met with senior officials at the As the year drew to a close, we accelerated our planning Office of Management and Budget and NIH. On October 5, I for FASEB’s centennial celebrations in 2012. The centennial met with Denny Rehberg, Chair of the House Labor, Health website www.fasebcentennial.org debuted at the end of and Human Services (LHHS) Appropriations Subcom- the year. If you have not already done so, take a look at this mittee, just a few days after he introduced a bill with a major fantastic overview of FASEB and its history. The Federation is funding increase for NIH. Throughout the year, FASEB wrote a very special organization, and its achievements are indeed letters, met with members of Congress and their staff, and worth celebrating. generated tens of thousands of e-mail messages in support of research funding. In collaboration with our advocacy And while our accomplishments have been exemplary, our partners, we were also able to significantly scale back organizational ascent continues. The Histochemical Society and phase-in a proposed increase in the Small Business became a member of FASEB in July. I am also proud to Innovation Research set-aside, which would have redirected announce that at our December meeting, the FASEB Board millions of dollars away from the competitive research grant of Directors approved the applications of two new member budgets at federal agencies at a particularly difficult time for societies, the Society for Pediatric Research and the Society scientists and engineers. for Glycobiology. We continue to lay the foundation for continued growth and enhanced effectiveness. Research policy issues continued to be a central concern. On March 24 and 25, FASEB held a major symposium on House LHHS Appropriations Dr. Francis Collins speaking Dr. Joseph C. LaManna and Dr. Joann A. Boughman at the IOM Subcommittee Chair Denny Rehberg and at FASEB conference on basic meeting on conflict of interest regulations FASEB President Dr. Joseph C. LaManna scientists in translational research 2 www.faseb.org The Federation of American Societies for Experimental Biology Guy Fogleman Executive Director’s Report FASEB logo in October. The centennial website went live in FASEB is a great organization December. The former Director of the National Institutes of with a distinguished history Health, Elias Zerhouni, the Former Chairman of the House and an important mission. Labor, Health and Human Services, and Education Appropri- ations Subcommittee, John Porter, the former Chief Scientific In 2011 we prepared for our centennial year while main- Officer of Bristol-Myers Squibb, Leon E. Rosenberg, and a taining our focus on FASEB’s role as the primary advocate number of FASEB past presidents have written testimonials for investigator-initiated biomedical research. The Office about FASEB for the centennial website. of Public Affairs worked diligently to implement many The Beaumont Campus capital improvement plan, approved aspects of our Strategic Map. We also completed a by the Board in 2007, was completed within budget and very active Science Research Conference season and ahead of schedule in May 2011. The columns and building successfully managed society annual meetings, including trim on the Lee Building were painted and the campus will Experimental Biology (EB). The Maximizing Access to sparkle for FASEB’s centennial. We implemented significant Research Careers (MARC) program sponsored exhibits improvements in the campus physical plant and information or Career Centers at EB and twelve other member society technology infrastructure, established a stable financing meetings, member society booths at the Annual Biomedical arrangement, and developed a new capital investment Research Conference for Minority Students and Society for strategy that will meet our future requirements without the Advancement of Chicanos and Native Americans in Science, need for additional debt. In May, the American Society for and over 300 travel awards to 23 different member society Biochemistry and Molecular Biology (ASBMB) moved off th events. The FASEB Journal celebrated its 25 anniversary. campus in order to expand their operations. We were sad to With the leadership and encouragement of William T. Talman lose one of FASEB’s founding members from our campus, (Immediate Past-President), all of our member societies are but we are happy to see that ASBMB is thriving and are now included in the FASEB directory. excited about their